326 related articles for article (PubMed ID: 30788552)
1. Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay.
Seo JE; Tryndyak V; Wu Q; Dreval K; Pogribny I; Bryant M; Zhou T; Robison TW; Mei N; Guo X
Arch Toxicol; 2019 May; 93(5):1433-1448. PubMed ID: 30788552
[TBL] [Abstract][Full Text] [Related]
2. Performance of high-throughput CometChip assay using primary human hepatocytes: a comparison of DNA damage responses with in vitro human hepatoma cell lines.
Seo JE; Wu Q; Bryant M; Ren L; Shi Q; Robison TW; Mei N; Manjanatha MG; Guo X
Arch Toxicol; 2020 Jun; 94(6):2207-2224. PubMed ID: 32318794
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an in vitro three-dimensional HepaRG spheroid model for genotoxicity testing using the high-throughput CometChip platform.
Seo JE; He X; Muskhelishvili L; Malhi P; Mei N; Manjanatha M; Bryant M; Zhou T; Robison T; Guo X
ALTEX; 2022; 39(4):583-604. PubMed ID: 35791290
[TBL] [Abstract][Full Text] [Related]
4. Performance of HepaRG and HepG2 cells in the high-throughput micronucleus assay for in vitro genotoxicity assessment.
Guo X; Seo JE; Petibone D; Tryndyak V; Lee UJ; Zhou T; Robison TW; Mei N
J Toxicol Environ Health A; 2020 Nov; 83(21-22):702-717. PubMed ID: 32981483
[TBL] [Abstract][Full Text] [Related]
5. Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta).
Seo JE; Davis K; Malhi P; He X; Bryant M; Talpos J; Burks S; Mei N; Guo X
Toxicology; 2021 Oct; 462():152936. PubMed ID: 34509578
[TBL] [Abstract][Full Text] [Related]
6. Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.
Seo JE; Yu JZ; Xu H; Li X; Atrakchi AH; McGovern TJ; Bruno KLD; Mei N; Heflich RH; Guo X
Arch Toxicol; 2023 Oct; 97(10):2785-2798. PubMed ID: 37486449
[TBL] [Abstract][Full Text] [Related]
7. High-throughput micronucleus assay using three-dimensional HepaRG spheroids for in vitro genotoxicity testing.
Seo JE; Li X; Le Y; Mei N; Zhou T; Guo X
Arch Toxicol; 2023 Apr; 97(4):1163-1175. PubMed ID: 36847820
[TBL] [Abstract][Full Text] [Related]
8. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
9. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
Sasaki YF; Sekihashi K; Izumiyama F; Nishidate E; Saga A; Ishida K; Tsuda S
Crit Rev Toxicol; 2000 Nov; 30(6):629-799. PubMed ID: 11145306
[TBL] [Abstract][Full Text] [Related]
10. [Research on the comet assay in vitro by plating HepG2 cells in 96-well plates].
Wang Z; Zhang T; Zhu Y; Zhu J
Wei Sheng Yan Jiu; 2007 Jan; 36(1):20-3. PubMed ID: 17424840
[TBL] [Abstract][Full Text] [Related]
11. Performance of comet and micronucleus assays in metabolic competent HepaRG cells to predict in vivo genotoxicity.
Le Hégarat L; Mourot A; Huet S; Vasseur L; Camus S; Chesné C; Fessard V
Toxicol Sci; 2014 Apr; 138(2):300-9. PubMed ID: 24431211
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the genotoxic potential of indirect chemical mutagens in HepaRG cells by the comet and the cytokinesis-block micronucleus assays.
Le Hegarat L; Dumont J; Josse R; Huet S; Lanceleur R; Mourot A; Poul JM; Guguen-Guillouzo C; Guillouzo A; Fessard V
Mutagenesis; 2010 Nov; 25(6):555-60. PubMed ID: 20675360
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of genotoxicity using automated detection of γH2AX in metabolically competent HepaRG cells.
Quesnot N; Rondel K; Audebert M; Martinais S; Glaise D; Morel F; Loyer P; Robin MA
Mutagenesis; 2016 Jan; 31(1):43-50. PubMed ID: 26282955
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay.
Mandon M; Huet S; Dubreil E; Fessard V; Le Hégarat L
Sci Rep; 2019 Jul; 9(1):10548. PubMed ID: 31332230
[TBL] [Abstract][Full Text] [Related]
15. The JaCVAM international validation study on the in vivo comet assay: Selection of test chemicals.
Morita T; Uno Y; Honma M; Kojima H; Hayashi M; Tice RR; Corvi R; Schechtman L
Mutat Res Genet Toxicol Environ Mutagen; 2015 Jul; 786-788():14-44. PubMed ID: 26212294
[TBL] [Abstract][Full Text] [Related]
16. Use of HepG2 cell line for direct or indirect mutagens screening: comparative investigation between comet and micronucleus assays.
Valentin-Severin I; Le Hegarat L; Lhuguenot JC; Le Bon AM; Chagnon MC
Mutat Res; 2003 Apr; 536(1-2):79-90. PubMed ID: 12694748
[TBL] [Abstract][Full Text] [Related]
17. Towards better prediction of xenobiotic genotoxicity: CometChip technology coupled with a 3D model of HepaRG human liver cells.
Barranger A; Le Hégarat L
Arch Toxicol; 2022 Jul; 96(7):2087-2095. PubMed ID: 35419617
[TBL] [Abstract][Full Text] [Related]
18. Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing.
Štampar M; Tomc J; Filipič M; Žegura B
Arch Toxicol; 2019 Nov; 93(11):3321-3333. PubMed ID: 31542801
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing.
Seo JE; Le Y; Revollo J; Miranda-Colon J; Xu H; McKinzie P; Mei N; Chen T; Heflich RH; Zhou T; Robison T; Bonzo JA; Guo X
Arch Toxicol; 2024 Jun; 98(6):1919-1935. PubMed ID: 38584193
[TBL] [Abstract][Full Text] [Related]
20. The development and validation of EpiComet-Chip, a modified high-throughput comet assay for the assessment of DNA methylation status.
Townsend TA; Parrish MC; Engelward BP; Manjanatha MG
Environ Mol Mutagen; 2017 Aug; 58(7):508-521. PubMed ID: 28755435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
